However, another study showed that VEGF-C was expressed at low levels in approximately 20% of bladder cancer patients with lymph node metastasis, suggesting lymphangiogenesis in these patients did not result from VEGF-C (Chen et al., 2020). The gene discussed is VEGFC; the disease is urinary bladder carcinoma.